Cargando…

Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes

OBJECTIVE: To develop and validate a parsimonious model for predicting short-term all-cause mortality in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Two cohorts of patients with T2DM were investigated. The Gargano Mortality Study (GMS, n = 679 patients) was the traini...

Descripción completa

Detalles Bibliográficos
Autores principales: De Cosmo, Salvatore, Copetti, Massimiliano, Lamacchia, Olga, Fontana, Andrea, Massa, Michela, Morini, Eleonora, Pacilli, Antonio, Fariello, Stefania, Palena, Antonio, Rauseo, Anna, Viti, Rafaella, Di Paola, Rosa, Menzaghi, Claudia, Cignarelli, Mauro, Pellegrini, Fabio, Trischitta, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747924/
https://www.ncbi.nlm.nih.gov/pubmed/23637348
http://dx.doi.org/10.2337/dc12-1906
_version_ 1782281005241991168
author De Cosmo, Salvatore
Copetti, Massimiliano
Lamacchia, Olga
Fontana, Andrea
Massa, Michela
Morini, Eleonora
Pacilli, Antonio
Fariello, Stefania
Palena, Antonio
Rauseo, Anna
Viti, Rafaella
Di Paola, Rosa
Menzaghi, Claudia
Cignarelli, Mauro
Pellegrini, Fabio
Trischitta, Vincenzo
author_facet De Cosmo, Salvatore
Copetti, Massimiliano
Lamacchia, Olga
Fontana, Andrea
Massa, Michela
Morini, Eleonora
Pacilli, Antonio
Fariello, Stefania
Palena, Antonio
Rauseo, Anna
Viti, Rafaella
Di Paola, Rosa
Menzaghi, Claudia
Cignarelli, Mauro
Pellegrini, Fabio
Trischitta, Vincenzo
author_sort De Cosmo, Salvatore
collection PubMed
description OBJECTIVE: To develop and validate a parsimonious model for predicting short-term all-cause mortality in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Two cohorts of patients with T2DM were investigated. The Gargano Mortality Study (GMS, n = 679 patients) was the training set and the Foggia Mortality Study (FMS, n = 936 patients) represented the validation sample. GMS and FMS cohorts were prospectively followed up for 7.40 ±2.15 and 4.51 ±1.69 years, respectively, and all-cause mortality was registered. A new forward variable selection within a multivariate Cox regression was implemented. Starting from the empty model, each step selected the predictor that, once included into the multivariate Cox model, yielded the maximum continuous net reclassification improvement (cNRI). The selection procedure stopped when no further statistically significant cNRI increase was detected. RESULTS: Nine variables (age, BMI, diastolic blood pressure, LDL cholesterol, triglycerides, HDL cholesterol, urine albumin-to-creatinine ratio, and antihypertensive and insulin therapy) were included in the final predictive model with a C statistic of 0.88 (95% CI 0.82–0.94) in the GMS and 0.82 (0.76–0.87) in the FMS. Finally, we used a recursive partition and amalgamation algorithm to identify patients at intermediate and high mortality risk (hazard ratio 7.0 and 24.4, respectively, as compared with those at low risk). A web-based risk calculator was also developed. CONCLUSIONS: We developed and validated a parsimonious all-cause mortality equation in T2DM, providing also a user-friendly web-based risk calculator. Our model may help prioritize the use of available resources for targeting aggressive preventive and treatment strategies in a subset of very high-risk individuals.
format Online
Article
Text
id pubmed-3747924
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-37479242014-09-01 Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes De Cosmo, Salvatore Copetti, Massimiliano Lamacchia, Olga Fontana, Andrea Massa, Michela Morini, Eleonora Pacilli, Antonio Fariello, Stefania Palena, Antonio Rauseo, Anna Viti, Rafaella Di Paola, Rosa Menzaghi, Claudia Cignarelli, Mauro Pellegrini, Fabio Trischitta, Vincenzo Diabetes Care Original Research OBJECTIVE: To develop and validate a parsimonious model for predicting short-term all-cause mortality in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Two cohorts of patients with T2DM were investigated. The Gargano Mortality Study (GMS, n = 679 patients) was the training set and the Foggia Mortality Study (FMS, n = 936 patients) represented the validation sample. GMS and FMS cohorts were prospectively followed up for 7.40 ±2.15 and 4.51 ±1.69 years, respectively, and all-cause mortality was registered. A new forward variable selection within a multivariate Cox regression was implemented. Starting from the empty model, each step selected the predictor that, once included into the multivariate Cox model, yielded the maximum continuous net reclassification improvement (cNRI). The selection procedure stopped when no further statistically significant cNRI increase was detected. RESULTS: Nine variables (age, BMI, diastolic blood pressure, LDL cholesterol, triglycerides, HDL cholesterol, urine albumin-to-creatinine ratio, and antihypertensive and insulin therapy) were included in the final predictive model with a C statistic of 0.88 (95% CI 0.82–0.94) in the GMS and 0.82 (0.76–0.87) in the FMS. Finally, we used a recursive partition and amalgamation algorithm to identify patients at intermediate and high mortality risk (hazard ratio 7.0 and 24.4, respectively, as compared with those at low risk). A web-based risk calculator was also developed. CONCLUSIONS: We developed and validated a parsimonious all-cause mortality equation in T2DM, providing also a user-friendly web-based risk calculator. Our model may help prioritize the use of available resources for targeting aggressive preventive and treatment strategies in a subset of very high-risk individuals. American Diabetes Association 2013-09 2013-08-13 /pmc/articles/PMC3747924/ /pubmed/23637348 http://dx.doi.org/10.2337/dc12-1906 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
De Cosmo, Salvatore
Copetti, Massimiliano
Lamacchia, Olga
Fontana, Andrea
Massa, Michela
Morini, Eleonora
Pacilli, Antonio
Fariello, Stefania
Palena, Antonio
Rauseo, Anna
Viti, Rafaella
Di Paola, Rosa
Menzaghi, Claudia
Cignarelli, Mauro
Pellegrini, Fabio
Trischitta, Vincenzo
Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes
title Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes
title_full Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes
title_fullStr Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes
title_full_unstemmed Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes
title_short Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes
title_sort development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747924/
https://www.ncbi.nlm.nih.gov/pubmed/23637348
http://dx.doi.org/10.2337/dc12-1906
work_keys_str_mv AT decosmosalvatore developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT copettimassimiliano developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT lamacchiaolga developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT fontanaandrea developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT massamichela developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT morinieleonora developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT pacilliantonio developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT fariellostefania developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT palenaantonio developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT rauseoanna developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT vitirafaella developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT dipaolarosa developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT menzaghiclaudia developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT cignarellimauro developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT pellegrinifabio developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes
AT trischittavincenzo developmentandvalidationofapredictingmodelofallcausemortalityinpatientswithtype2diabetes